IL-6-independent expression of Mcl-1 in human multiple myeloma (Q48010145)

7 February 2018

title

IL-6-independent expression of Mcl-1 in human multiple myeloma (English)

1 reference

7 February 2018

author name string

Bin Zhang

series ordinal

1

1 reference

7 February 2018

Valeria Potyagaylo

series ordinal

2

1 reference

7 February 2018

Robert G Fenton

series ordinal

3

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2003

1 reference

7 February 2018

published in

Oncogene

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

12

1 reference

7 February 2018

page(s)

1848-1859

1 reference

7 February 2018

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Breaking the mitochondrial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Functional analysis of the human MCL-1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Common themes in the pathogenesis of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Chromosome translocations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Plasma cells: finding new light at the end of B cell development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Impaired Fas response and autoimmunity in Pten+/- mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Cytogenetic abnormalities in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

BH3-Only proteins-essential initiators of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Regulatory mechanisms controlling hematopoiesis: principles and problems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Social controls on cell survival and cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Prognostic factors in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Humoral immunity due to long-lived plasma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Myeloid cell factor-1 is a critical survival factor for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206358

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206358

1 reference

7 February 2018

Dimensions Publication ID

1020495237

0 references

Fatcat ID

release_ror3bz673fge3ioarrx6h3qjv4

0 references

1 reference

7 February 2018